RNA
Avidity Biosciences Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website aviditybiosciences.com
- Employees(FY) 186
- ISIN US05370A1088
Performance
+8.86%
1W
+23.38%
1M
+108.04%
3M
+397.47%
6M
+225.97%
YTD
+167.94%
1Y
Profile
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Investment Analysis Report: RNA
Overview
RNA is a biotechnology company operating in the Health Technology sector with a market capitalization of $1.05 billion. In this report, we will conduct a comprehensive analysis of RNA's financial statements over the past three years to evaluate its valuation, financial health, earnings and revenue growth,...
Technical Analysis of RNA 2024-05-10
Overview:
In the last 5 trading days, RNA's stock price has shown some fluctuations, with a mix of positive and negative movements. By analyzing various technical indicators such as trend, momentum, volatility, and volume, we can gain insights into the possible future price movement of RNA stock.
Trend Analysis:
- Moving Averages (MA): The 5-day ...
Recent News & Updates
- 2024-05-19 09:03
- 2024-05-17 03:24
- 2024-05-15 09:00
- 2024-05-14 21:00
- 2024-05-09 16:05
- 2024-05-09 11:55
- 2024-05-09 04:05
- 2024-05-08 16:05
- 2024-05-08 12:27
- 2024-05-08 06:00
- 2024-05-08 04:05
- 2024-05-07 18:00
- 2024-04-22 16:05
- 2024-04-22 04:05
- 2024-04-04 01:30
- 2024-03-27 09:00
- 2024-03-26 21:00
- 2024-03-21 16:05
- 2024-03-21 04:05
- 2024-03-15 19:01
- 2024-03-04 16:02
Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy(Investor's Business Daily)
- 2024-03-04 07:00
- 2024-03-03 18:00
- 2024-03-01 06:43
Avidity Biosciences Full Year 2023 Earnings: Misses Expectations(Simply Wall St.)
- 2024-02-29 12:00
Avidity Biosciences Honors Rare Disease Day®(PR Newswire)
- 2024-02-29 07:00
- 2024-02-28 23:00
Avidity Biosciences Honors Rare Disease Day(Prnewswire)
- 2024-02-28 18:00
- 2024-02-28 17:20
- 2024-02-28 16:40
Page 1 of 6
previousnext